Related content

NSAID use and survival after breast cancer diagnosis in post-menopausal women

By Blair Cindy   Sweeney Carol   Anderson Kristin   Folsom Aaron  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008

By Land Lotte  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 1013-1020

Springer Publishing Company

Access to resources Recommend Favorite

The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study

By Frechette Dominique   Paquet Lise   Verma Shailendra   Clemons Mark   Wheatley-Price Paul   Gertler Stan   Song Xinni   Graham Nadine   Dent Susan  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 111-117

Springer Publishing Company

Access to resources Recommend Favorite

Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

By Kyvernitakis I.   Knöll D.   Struck M.   Hars O.   Bauer T.   Hadji P.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Anastrozole (Arimidex(TM)) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

By Nabholtz J.M.   Bonneterre J.   Buzdar A.   Robertson J.F.R.   Thurlimann B.   for the Arimidex Writing Committee on behalf of the Investigators  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1684-1689

Elsevier

Access to resources Recommend Favorite